NCT02761057 2025-01-13Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has ProgressedNational Cancer Institute (NCI)Phase 2 Completed152 enrolled 19 charts
NCT05112627 2024-08-09Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative TherapyMayo ClinicCompleted15 enrolled